Iovance Biotherapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell IOVA and other ETFs, options, and stocks.About IOVA
Iovance Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of cell therapies as novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes (TIL), which are T cells derived from patients' tumors.
IOVA Key Statistics
Stock Snapshot
As of today, Iovance Biotherapeutics(IOVA) shares are valued at $4.01. The company's market cap stands at 1.65B, with a P/E ratio of -3.58.
On 2026-04-10, Iovance Biotherapeutics(IOVA) stock moved within a range of $3.99 to $4.04. With shares now at $4.01, the stock is trading +0.4% above its intraday low and -0.8% below the session's peak.
Trading activity shows a volume of 126.41K, compared to an average daily volume of 11.58M.
The stock's 52-week range extends from a low of $1.64 to a high of $5.63.
The stock's 52-week range extends from a low of $1.64 to a high of $5.63.
IOVA News
In recent months, Iovance Biotherapeutics has reported real-world data for Amtagvi showing higher response and disease control rates than its pivotal trial, rei...
Advertisement Amtagvi data and pipeline momentum reshape the story for Iovance Biotherapeutics (IOVA) The latest move in Iovance Biotherapeutics (IOVA) has be...
Analyst ratings
73%
of 11 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.